Sevelamer side effects
Pro Research Analysisby 
Searched over 200M research papers
Sevelamer Side Effects: A Comprehensive Overview
Introduction to Sevelamer and Its Uses
Sevelamer is a non-calcium-based phosphate binder commonly used to manage hyperphosphatemia in patients with chronic kidney disease (CKD), particularly those undergoing dialysis. While it is effective in controlling phosphate levels, sevelamer is associated with a range of side effects that can impact patient health and treatment outcomes.
Common Gastrointestinal Side Effects
Nausea, Vomiting, and Abdominal Pain
The most frequently reported side effects of sevelamer are gastrointestinal in nature, including nausea, vomiting, and abdominal pain. These symptoms are well-documented and are often considered manageable with appropriate medical intervention .
Severe Gastrointestinal Complications
In rare cases, sevelamer can cause more severe gastrointestinal issues. There have been reports of sevelamer crystals depositing in the gastrointestinal tract, leading to mucosal injury, pseudotumors, or even obstructions. These complications can result in significant morbidity and may require surgical intervention 18. For instance, a case study highlighted a pediatric patient who developed severe abdominal pain and a high-grade stricture of the sigmoid colon, necessitating a partial colectomy .
Crystal Deposition and Associated Risks
Gastrointestinal Tract and Beyond
Sevelamer crystals have been found not only in the gastrointestinal tract but also in other tissues. A notable case reported the presence of these crystals in the lung parenchyma and aortic wall, suggesting that sevelamer can deposit in multiple organ systems, potentially leading to complex clinical scenarios .
Histopathological Findings
Histopathological examinations often reveal the characteristic "fish scale" morphology of sevelamer crystals, which can cause tissue necrosis and autolysis. These findings underscore the importance of recognizing the potential for sevelamer to cause significant tissue damage .
Cardiovascular and Metabolic Effects
Impact on Lipid Levels and Inflammation
Sevelamer has been shown to have beneficial effects on lipid profiles and inflammatory markers. Studies indicate that sevelamer can reduce levels of low-density lipoprotein (LDL) cholesterol, oxidized LDL cholesterol, and inflammatory cytokines such as interleukin-6 and -8 246. These effects may confer cardiovascular benefits, although the clinical significance of these findings requires further investigation.
Effects on Vascular Calcification
While sevelamer is associated with reduced vascular calcification scores and lower serum phosphate levels compared to calcium-based binders, its impact on long-term cardiovascular outcomes remains uncertain. Some studies suggest that sevelamer may not significantly improve left ventricular mass or arterial stiffness in CKD patients 510.
Other Notable Side Effects
Hypophosphatemia and Metabolic Changes
Sevelamer can occasionally cause hypophosphatemia, particularly in patients with lower baseline phosphate levels. Additionally, it has been associated with reductions in C-reactive protein (CRP), glycated hemoglobin (HbA1c), and advanced glycation end products (AGEs), which may have implications for metabolic control in diabetic patients with CKD 36.
Safety in Special Populations
In patients with untreated HIV infection, sevelamer did not significantly change markers of microbial translocation or inflammation but did reduce levels of soluble tissue factor and LDL cholesterol, suggesting potential cardiovascular benefits in this population as well .
Conclusion
Sevelamer is an effective phosphate binder with a range of side effects that can impact patient management. While common gastrointestinal symptoms are often manageable, more severe complications such as crystal deposition and tissue injury require careful monitoring. Additionally, sevelamer's effects on lipid profiles and inflammation may offer cardiovascular benefits, although further research is needed to fully understand its long-term impact. Clinicians should weigh these potential risks and benefits when prescribing sevelamer, particularly in patients with complex medical histories.
Sources and full results
Most relevant research papers on this topic
Effects of Sevelamer Carbonate in Patients With CKD and Proteinuria: The ANSWER Randomized Trial.
Sevelamer carbonate may enhance the antiproteinuric effect of RAS inhibitors in patients with chronic kidney disease and proteinuria, but its long-term safety and effectiveness remain unclear.
Effects of sevelamer on HbA1c, inflammation, and advanced glycation end products in diabetic kidney disease.
Sevelamer carbonate significantly reduces HbA1c, inflammation, and oxidative stress markers, and increases antioxidant markers in patients with diabetes and early kidney disease, independent of phosphorus levels.
Systematic review of the clinical efficacy and safety of sevelamer in dialysis patients.
Sevelamer is associated with slightly higher phosphate levels and slightly lower serum calcium levels in dialysis patients, but does not significantly reduce all-cause mortality, cardiovascular mortality, or bone disease frequency.
DOI